Archive - February 2018
Merck and Pfizer’s immunotherapy fails in late-stage trial
Horizon painkiller price has jumped 2000 percent since 2013
Horizon’s faced repeated price-hike criticism, but Vimovo just got its 11th raise—to almost $3,000
Arthritis patient group launches interactive video initiative
Six state regulators now scrutinizing Aetna prior-authorization practices
When One Teen Vapes, Others Often Follow
1 in 10 Worldwide Gets Wound Infection After Abdominal Surgery
Federal, Illinois regulators approve Advocate-Aurora merger